TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Impaired Driving Risks Could Give the Government Second Thoughts About Legalizing Pot
Investing
Are We Seeing a Cannabis Bubble Begin to Form?
Investing
2 Big Reasons Marijuana Legalization Could Still Be Delayed
Investing
Why Investors of Canopy Growth Corp. Should Be Concerned
Investing
Canopy Growth Corp.: Is This the Best Marijuana Play?
Investing
Why Quebec’s Plans for Cannabis Could Hurt Growth in the Industry
Investing
Is Canopy Growth Corp. a Buy at These Levels?
Investing
Why More Major Companies May Want a Weed Deal of Their Own With Canadian Marijuana Producers
Investing
Consolidation in the Marijuana Industry: Aurora Cannabis Inc. Wants to Acquire CanniMed Therapeutics Inc.
Investing
Why Investors Should Be Concerned About Canopy Growth Corp.’s Q2 Results
Investing
Why Dollarama Inc. Is a Better Buy Than Canopy Growth Corp.